Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristian Reich

Showing results (31-40 of 265) with videos related to

Pageof 27
Sort By:
The Journal of Dermatological Treatment|June 24, 2008
Silica gel is as effective as acyclovir cream in patients with recurrent herpes labialis: results of a randomized, open-label trialIna Zschocke, Christine Reich, Andrea Zielke, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 9, 2009
[Statement of the DDG and the BVDD on the EMEA recommendations the use of raptiva [efalizumab]]Thomas Luger, Michael Reusch, Kristian Reich, et al.
Archives of Dermatological Research|February 11, 2014
Assessing adherence factors in patients under topical treatment: development of the Topical Therapy Adherence Questionnaire (TTAQ)Ina Zschocke, Ulrich Mrowietz, Annett Lotzin, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 2, 2011
Systemic treatment with corticosteroids in psoriasis--health care provision far beyond the S3-guidelinesMatthias Augustin, Ines Schäfer, Kristian Reich, et al.
Contact Dermatitis|December 21, 2010
Genetic factors in contact allergy--review and future goalsAxel Schnuch, Götz Westphal, Rotraut Mössner, et al.
Lancet (London, England)|April 25, 2021
IL17A/F nanobody sonelokimab in patients with plaque psoriasis: a multicentre, randomised, placebo-controlled, phase 2b studyKim A Papp, Mark A Weinberg, Alun Morris, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 13, 2017
Extensive hyperpigmentation of the face in a FilipinaJohanna Pirrone, Jasmin Broyer, Nicola Otte, et al.
Skin Health and Disease|March 24, 2025
Favourable response of Blaschko linear psoriasis to interleukin-23 inhibitionJeremias L K Reich, Alexandros Onoufriadis, John A McGrath, et al.
Dermatology and Therapy|December 6, 2021
Nail Involvement as a Predictor of Differential Treatment Effects of Secukinumab Versus Ustekinumab in Patients with Moderate to Severe PsoriasisCurdin Conrad, Christine-Elke Ortmann, Marc Vandemeulebroecke, et al.
American Journal of Clinical Dermatology|November 9, 2015
Adalimumab Efficacy in Patients with Psoriasis Who Received or Did Not Respond to Prior Systemic Therapy: A Pooled Post Hoc Analysis of Results from Three Double-Blind, Placebo-Controlled Clinical TrialsKim A Papp, April W Armstrong, Kristian Reich, et al.
Pageof 27

Showing results (31-40 of 265) with videos related to

Sort By:
Pageof 27
The Journal of Dermatological Treatment|June 24, 2008
Silica gel is as effective as acyclovir cream in patients with recurrent herpes labialis: results of a randomized, open-label trialIna Zschocke, Christine Reich, Andrea Zielke, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 9, 2009
[Statement of the DDG and the BVDD on the EMEA recommendations the use of raptiva [efalizumab]]Thomas Luger, Michael Reusch, Kristian Reich, et al.
Archives of Dermatological Research|February 11, 2014
Assessing adherence factors in patients under topical treatment: development of the Topical Therapy Adherence Questionnaire (TTAQ)Ina Zschocke, Ulrich Mrowietz, Annett Lotzin, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 2, 2011
Systemic treatment with corticosteroids in psoriasis--health care provision far beyond the S3-guidelinesMatthias Augustin, Ines Schäfer, Kristian Reich, et al.
Contact Dermatitis|December 21, 2010
Genetic factors in contact allergy--review and future goalsAxel Schnuch, Götz Westphal, Rotraut Mössner, et al.
Lancet (London, England)|April 25, 2021
IL17A/F nanobody sonelokimab in patients with plaque psoriasis: a multicentre, randomised, placebo-controlled, phase 2b studyKim A Papp, Mark A Weinberg, Alun Morris, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 13, 2017
Extensive hyperpigmentation of the face in a FilipinaJohanna Pirrone, Jasmin Broyer, Nicola Otte, et al.
Skin Health and Disease|March 24, 2025
Favourable response of Blaschko linear psoriasis to interleukin-23 inhibitionJeremias L K Reich, Alexandros Onoufriadis, John A McGrath, et al.
Dermatology and Therapy|December 6, 2021
Nail Involvement as a Predictor of Differential Treatment Effects of Secukinumab Versus Ustekinumab in Patients with Moderate to Severe PsoriasisCurdin Conrad, Christine-Elke Ortmann, Marc Vandemeulebroecke, et al.
American Journal of Clinical Dermatology|November 9, 2015
Adalimumab Efficacy in Patients with Psoriasis Who Received or Did Not Respond to Prior Systemic Therapy: A Pooled Post Hoc Analysis of Results from Three Double-Blind, Placebo-Controlled Clinical TrialsKim A Papp, April W Armstrong, Kristian Reich, et al.
Pageof 27